Literature DB >> 33197394

Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India.

Anup Malani1, Daksha Shah2, Gagandeep Kang3, Gayatri Nair Lobo4, Jayanthi Shastri5, Manoj Mohanan6, Rajesh Jain7, Sachee Agrawal8, Sandeep Juneja9, Sofia Imad10, Ullas Kolthur-Seetharam11.   

Abstract

Entities:  

Year:  2020        PMID： 33197394     DOI： 10.1016/S2214-109X(20)30467-8

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN： 2214-109X            Impact factor:   26.763


× No keyword cloud information.
  40 in total

1.  Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021.

Authors:  Rubhana Raqib; Protim Sarker; Evana Akhtar; Tarique Mohammad Nurul Huda; Md Ahsanul Haq; Anjan Kumar Roy; Md Biplob Hosen; Farjana Haque; Md Razib Chowdhury; Daniel D Reidpath; Dewan Md Emdadul Hoque; Zahirul Islam; Shehlina Ahmed; Tahmeed Ahmed; Fahmida Tofail; Abdur Razzaque
Journal:  PLoS One       Date:  2022-05-23       Impact factor: 3.752

2.  Structural factors contributing to SARS-CoV-2 infection risk in the urban slum setting.

Authors:  Mariam O Fofana; Nivison Nery; Juan P Aguilar Ticona; Emilia M M A Belitardo; Renato Victoriano; Rôsangela O Anjos; Moyra M Portilho; Mayara C de Santana; Laiara L Dos Santos; Daiana de Oliveira; Jaqueline S Cruz; M Cate Muencker; Ricardo Khouri; Elsio A Wunder; Matthew D T Hitchings; Olatunji Johnson; Mitermayer G Reis; Guilherme S Ribeiro; Derek A T Cummings; Federico Costa; Albert I Ko
Journal:  medRxiv       Date:  2022-02-15

3.  Thinking clearly about social aspects of infectious disease transmission.

Authors:  Caroline Buckee; Abdisalan Noor; Lisa Sattenspiel
Journal:  Nature       Date:  2021-06-30       Impact factor: 49.962

4.  Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys.

Authors:  Jaya Singh Kshatri; Debdutta Bhattacharya; Ira Praharaj; Asit Mansingh; Debaprasad Parai; Srikanta Kanungo; Subrata Kumar Palo; Sidhartha Giri; Matrujyoti Pattnaik; Shakti Ranjan Barik; Girish Chandra Dash; Hari Ram Choudhary; Jyotirmayee Turuk; Nitya Nanda Mandal; Sanghamitra Pati
Journal:  Epidemiol Infect       Date:  2021-04-27       Impact factor: 2.451

5.  SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.

Authors:  Manoj V Murhekar; Tarun Bhatnagar; Sriram Selvaraju; V Saravanakumar; Jeromie Wesley Vivian Thangaraj; Naman Shah; Muthusamy Santhosh Kumar; Kiran Rade; R Sabarinathan; Smita Asthana; Rakesh Balachandar; Sampada Dipak Bangar; Avi Kumar Bansal; Jyothi Bhat; Vishal Chopra; Dasarathi Das; Alok Kumar Deb; Kangjam Rekha Devi; Gaurav Raj Dwivedi; S Muhammad Salim Khan; C P Girish Kumar; M Sunil Kumar; Avula Laxmaiah; Major Madhukar; Amarendra Mahapatra; Suman Sundar Mohanty; Chethana Rangaraju; Alka Turuk; Dinesh Kumar Baradwaj; Ashrafjit S Chahal; Falguni Debnath; Inaamul Haq; Arshad Kalliath; Srikanta Kanungo; Jaya Singh Kshatri; G G J Naga Lakshmi; Anindya Mitra; A R Nirmala; Ganta Venkata Prasad; Mariya Amin Qurieshi; Seema Sahay; Ramesh Kumar Sangwan; Krithikaa Sekar; Vijay Kumar Shukla; Prashant Kumar Singh; Pushpendra Singh; Rajeev Singh; Dantuluri Sheethal Varma; Ankit Viramgami; Samiran Panda; D C S Reddy; Balram Bhargava
Journal:  Lancet Glob Health       Date:  2021-01-27       Impact factor: 26.763

6.  Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic.

Authors:  Lewis F Buss; Carlos A Prete; Claudia M M Abrahim; Alfredo Mendrone; Tassila Salomon; Cesar de Almeida-Neto; Rafael F O França; Maria C Belotti; Maria P S S Carvalho; Allyson G Costa; Myuki A E Crispim; Suzete C Ferreira; Nelson A Fraiji; Susie Gurzenda; Charles Whittaker; Leonardo T Kamaura; Pedro L Takecian; Pedro da Silva Peixoto; Marcio K Oikawa; Anna S Nishiya; Vanderson Rocha; Nanci A Salles; Andreza Aruska de Souza Santos; Martirene A da Silva; Brian Custer; Kris V Parag; Manoel Barral-Netto; Moritz U G Kraemer; Rafael H M Pereira; Oliver G Pybus; Michael P Busch; Márcia C Castro; Christopher Dye; Vítor H Nascimento; Nuno R Faria; Ester C Sabino
Journal:  Science       Date:  2020-12-08       Impact factor: 47.728

7.  Reported health and social consequences of the COVID-19 pandemic on vulnerable populations and implemented solutions in six West African countries: A media content analysis.

Authors:  Khalida Saalim; Kwame S Sakyi; Emily Morrison; Prince Owusu; Sarah L Dalglish; Mufaro Kanyangarara
Journal:  PLoS One       Date:  2021-06-16       Impact factor: 3.240

8.  SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination.

Authors:  Markus Hoffmann; Heike Hofmann-Winkler; Nadine Krüger; Amy Kempf; Inga Nehlmeier; Luise Graichen; Prerna Arora; Anzhalika Sidarovich; Anna-Sophie Moldenhauer; Martin S Winkler; Sebastian Schulz; Hans-Martin Jäck; Metodi V Stankov; Georg M N Behrens; Stefan Pöhlmann
Journal:  Cell Rep       Date:  2021-06-29       Impact factor: 9.423

9.  COVID-19 in India: Who are we leaving behind?

Authors:  Emmanuel Raju; Anwesha Dutta; Sonja Ayeb-Karlsson
Journal:  Prog Disaster Sci       Date:  2021-03-24

10.  COVID-19, the Built Environment, and Health.

Authors:  Howard Frumkin
Journal:  Environ Health Perspect       Date:  2021-07-21       Impact factor: 9.031
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.